European Chemicals Agency
European Chemicals Agency
The European Chemicals Agency (ECHA) is an agency of the European Union (EU) which manages the technical, scientific, and administrative aspects of the EU's chemicals legislation. ECHA was established in 2007 and is headquartered in Helsinki, Finland. The agency plays a crucial role in implementing the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation, which aims to ensure a high level of protection for human health and the environment from the risks posed by chemicals.
History[edit]
ECHA was established by the European Commission in 2007 to oversee the implementation of the REACH regulation. The agency was created to centralize and streamline the process of chemical regulation within the EU, ensuring that chemicals are used safely and responsibly.
Functions[edit]
ECHA's primary functions include:
- Managing the registration of chemicals produced or imported into the EU in quantities of one tonne or more per year.
- Evaluating the information submitted by companies to ensure compliance with REACH requirements.
- Authorizing the use of substances of very high concern (SVHCs) and restricting the use of hazardous chemicals.
- Providing information on chemicals to the public and promoting the safe use of chemicals.
Structure[edit]
ECHA is governed by a Management Board, which includes representatives from the European Commission, EU member states, and stakeholders. The agency is divided into several directorates, each responsible for different aspects of its work, including registration, evaluation, authorization, and restriction of chemicals.
Key Regulations[edit]
ECHA is responsible for implementing several key pieces of EU chemicals legislation, including:
- REACH Regulation
- Classification, Labelling and Packaging (CLP) Regulation
- Biocidal Products Regulation (BPR)
- Prior Informed Consent (PIC) Regulation
Related Pages[edit]
- European Union
- European Commission
- REACH Regulation
- Classification, Labelling and Packaging
- Biocidal Products Regulation
- Prior Informed Consent
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian